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Abstract: Nitrite was once thought to be inert in human
physiology. However, research over the past few decades
has established a link between nitrite and the production
of nitric oxide (NO) that is potentiated under hypoxic and
acidic conditions. Under this new role nitrite acts as a storage pool for bioavailable NO. The NO so produced is likely to
play important roles in decreasing platelet activation, contributing to hypoxic vasodilation and minimizing blood-cell
adhesion to endothelial cells. Researchers have proposed
multiple mechanisms for nitrite reduction in the blood.
However, NO production in blood must somehow overcome
rapid scavenging by hemoglobin in order to be effective.
Here we review the role of red blood cell hemoglobin in the
reduction of nitrite and present recent research into mechanisms that may allow nitric oxide and other reactive nitrogen signaling species to escape the red blood cell.
Keywords: erythrocyte; hemoglobin; hypoxia; nitric
oxide; vasodilation.

Introduction: nitric oxide in the
blood
Endothelium-derived nitric oxide (NO) is an important cardiovascular signaling molecule whose production increases
blood flow, reduces blood pressure, decreases blood cell
adhesion, and diminishes platelet activation. In normoxic
conditions, nitric oxide synthase (NOS) found on endothelial cells and red blood cells catalyzes the production of
NO and L-citrulline from molecular oxygen and L-arginine
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(Andrew and Mayer, 1999; Forstermann and Sessa, 2012).
The source of normoxic vasodilation is widely believed to
be endothelium derived NO (Moncada and Higgs, 1993).
As oxygen is a substrate for NOS, at low oxygen levels NO
production by NOS is diminished (Totzeck et al., 2012).
Therefore, at low oxygen tension mechanisms of hypoxic
NO production, such as nitrite reduction by deoxygenated
hemoglobin (Hb) in red blood cells (RBCs) can take over.
Hb is present in the blood at a concentration of about
10 mm and Hb rapidly scavenges NO. NO reacts with oxygenated Hb (oxyHb) at a rate of 5–6 × 107 m−1 s−1 and deoxygenated Hb (deoxyHb) at a rate of 2–6 × 107 m−1 s−1 (Cassoly
and Gibson, 1975; Morris and Gibson, 1980; Doyle et al.,
1981; Cooper, 1999; Kim-Shapiro et al., 2006). Additionally, NO has a high affinity for Hb, with a dissociation constant of about 10−11–10−12 (Cooper, 1999).
Although Hb is abundant in the blood it is compartmentalized to the RBC and the RBC is pushed to the center of the
blood vessel in circulation. These mechanisms keep the Hb
away from the endothelium, a major source of NO in oxygenated conditions, and minimize NO scavenging (Lancaster,
1994; Butler et al., 1998; Liu et al., 1998; Liao et al., 1999).
However, in deoxygenated and acidic conditions
when the NOS no longer efficiently produces NO, the RBC
has been shown to play a role in NO production through
the use of nitrite. Therefore, it is important to determine
how NO can be produced by nitrite and the RBC and how
NO or another reactive nitrogen signaling species can
escape the Hb rich RBC.

Nitrite acquisition
Nitrite concentration in the blood is derived through two
main mechanisms. First, nitrite is formed from the oxidation of nitric oxide (NO) produced by nitric oxide synthase, found in the RBC itself and in endothelial cells
(Kleinbongard et al., 2003, 2006; Cortese-Krott et al.,
2012; Grau et al., 2013; Wood et al., 2013; Bizjak et al.,
2015). The auto-oxidation of NO to nitrite proceeds slowly
(k = 2 × 106 m−2 s−1) compared to oxidation of nitric oxide
to nitrate by hemoglobin (k = 8 × 107 m−1 s−1) (Shiva, 2012).
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However, ceruloplasmin in the plasma can catalyze the
conversion of NO to nitrite (Shiva et al., 2006). The oxidation of endothelial derived NO accounts for roughly 70%
of resting plasma nitrite (Kleinbongard et al., 2003). This
is an approximation as it is difficult to quantitatively estimate the participation of each source of plasma nitrite as
there could be interactions between nitrite sources.
Secondly, nitrite is obtained through dietary consumption. Nitrite, found in cured meats and cereal products, is efficiently absorbed by the intestines (Fritsch
et al., 1979; Lundberg et al., 2008). However, the main
dietary source of plasma nitrite is reduced dietary nitrate.
Nitrate is found at high levels in root and leaf vegetables
(Hord et al., 2009; Machha and Schechter, 2011). In the
mouth some of the nitrate is converted to nitrite by anaerobic bacteria (Tannenbaum et al., 1976; Duncan et al.,
1995). The nitrate and nitrite travel to the intestine where
again part of it is absorbed and makes its way into the
blood stream (Fritsch et al., 1979) and part passes on to be
excreted in the urine (Carlsson et al., 2001). At this point
a spiraling process begins where nitrate in the plasma is
absorbed, concentrated and excreted in the saliva where
it then interacts with bacteria in the mouth and is reduced
to nitrite then travels to the intestine and so on (Lundberg
et al., 2008). Endothelial and dietary derived nitrite lead
to total plasma nitrite levels between 50 and 350 nm (Kelm
et al., 1999; Rassaf et al., 2004; Lundberg et al., 2008).

Nitrite interactions
Nitrite was originally thought to be a biochemically inert
end product in plasma (Lauer et al., 2001). However, for
the past few decades this belief has been upturned and
nitrite is now regarded as a storage pool for NO. Gladwin
et al. (2000) measured significant arterial-venous plasma
nitrite gradients indicating the consumption of nitrite
during it transit to a lower PO2 and studies by Cosby et al.
showed nitrite infused into human forearms at physiological levels leads to vasodilation, a response indicative of
NO production (Cosby et al., 2003). Multiple studies investigating the effect of nitrate consumption show increases
in plasma nitrite are associated with a decrease in blood
pressure, antiplatelet properties, a decrease in leukocyte
adhesion, and an increase blood flow; all known signaling effects of NO (Jansson et al., 2008; Webb et al., 2008a;
Stokes et al., 2009; Presley et al., 2011; Srihirun et al.,
2012; Liu et al., 2015; Wightman et al., 2015).
Dietary studies add additional complexities such as
the effect of the acidic reduction of nitrite in the stomach

which can be enhanced by the consumption of polyphenol and/or ascorbic acid (Moriya et al., 2002; Takahama
et al., 2002; Peri et al., 2005; Gago et al., 2007). For
example, Medina-Remón et al. measured the influence
of the Mediterranean diet, which is high in polyphenols,
on plasma nitrite, plasma nitrate and blood pressure.
They found that eating the Mediterranean high in polyphenols decreased blood pressure and increased plasma
nitrite and nitrate and they attributed these effects to the
catalyzed reduction of nitrite in the gut by polyphenols.
However, the study did not measure the total intake of
nitrite and nitrate and therefore it is not certain whether
the measured effects are due to acidic reduction in the gut
or increased nitrite in the blood stream due to consumption of nitrite and nitrate (Medina-Remón et al., 2015).
The above in vivo studies clearly point to a mechanism
involving nitrite that leads to vasodilation. To identify the
mechanism responsible for nitrite reduction, studies have
investigated nitrite reduction by deoxygenated hemoglobin, xanthine oxidoreductase, carbonic anhydrase and
deoxygenated myoglobin in the blood vessel, acid in the
stomach, and bacteria in the oral cavity (Duncan et al.,
1995; McKnight et al., 1997; Huang et al., 2005b; Webb
et al., 2008b; Aamand et al., 2009; Totzeck et al., 2012; Tiso
and Schechter, 2015). Additionally, studies have examined
increased ATP production by red blood cells (RBCs) in the
presence of nitrite and subsequent ATP release by red blood
cells followed by stimulation of endothelial nitric oxide
synthase (Dietrich et al., 2000; Cao et al., 2009). Each of
these mechanisms are capable of producing NO and may
contribute to the overall bioavailability of NO (see Figure 1).

Support for the deoxyRBC and
nitrite pathway
The role of deoxygenated RBCs in nitrite bio-activation is
evident from in vitro and in vivo studies where the addition of deoxygenated RBCs and nitrite lead to vasodilation
(Cosby et al., 2003; Jensen and Agnisola, 2005; Crawford
et al., 2006). In these studies, vasodilation was diminished
when nitrite or RBCs were infused alone (Cosby et al.,
2003; Jensen and Agnisola, 2005; Crawford et al., 2006).
One explanation for increased NO production following
RBC and nitrite exposure is the increased synthesis of RBC
ATP in the presences of nitrite (Cao et al., 2009) followed
by the hypoxic release of ATP from RBCs which then stimulates NOS (McMahon et al., 2002; Crawford et al., 2006).
However, a response indicative of NO production is often
seen in the presence of NOS inhibitors L-NAME or LMMA,
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Figure 1: Mechanism of nitrite reduction.
We comprised a non-extensive collection of molecules and bacteria that reduce nitrite to NO and indicate where they are most commonly
found.

suggesting ATP release by RBCs cannot be the sole mechanism responsible for vasodilation (Crawford et al., 2006;
Liu et al., 2015). Others have shown an intrinsic vasodilation of vessels exposed to nitrite under hypoxic conditions
in the absence of RBCs (Dalsgaard et al., 2007; Isbell et al.,
2007), however, the timescale of this response does not
match the timescale of transit from arteries to veins and
the response to nitrite is increased in the presence of RBC
(Crawford et al., 2006; Allen et al., 2009). Together these
data points to a RBC mechanism that reduces nitrite to NO
under deoxygenated conditions.
Very strong support for the role of RBCs in bioactivation of nitrite comes from studies of platelet activation
and aggregation (Srihirun et al., 2012; Park et al., 2014;
Liu et al., 2015; Wajih et al., 2016). When nitrite is added
to platelet rich plasma after platelet activation is induced
by ADP or another agent, there is no effect unless deoxyRBCs are present (Srihirun et al., 2012). When deoxyRBCs
are present, the nitrite leads to inhibition of platelet activation and aggregation and this inhibition is potentiated
by hypoxia but abrogated when a NO scavenger is added
(Srihirun et al., 2012; Wajih et al., 2016). These affects
are also observed in slowing down clot formation and
maximum strength (Park et al., 2014). Importantly, effects

are seen at physiological levels of nitrite (Srihirun et al.,
2012; Park et al., 2014; Liu et al., 2015; Wajih et al., 2016).
Additional in vitro studies exclude other mechanisms
from playing a large role in nitrite reduction by deoxygenated red blood cells. We recently showed that xanthine
oxidoreductase does not play a large role in RBC mediated
bio-activation of nitrite. In fact, the inhibition of xanthine
oxidoreductase by allopurinol did not significantly change
the production of NO (Liu et al., 2015). Additionally, inhibition of carbonic anhydrase did not affect the production
of NO in the presence of nitrite and RBC when measured
by EPR and chemiluminescence and only affected platelet
activation at nonphysiological carbon dioxide concentration (Liu et al., 2015), suggesting that carbonic anhydrase
is not the major source of nitrite reduction by RBCs. These
data support the hypothesis that hemoglobin plays a
prominent role in nitrite reduction by RBCs.

Nitrite interactions with Hb
Nitrite reacts with oxyHb, deoxyHb and methemoglobin
(metHb). Nitrite reacts with oxyHb to form metHb and
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nitrate. The oxyHb/nitrite reaction is autocatalytic at
high ratios of nitrite to hemoglobin and involves H2O2 and
NO2. However, the autocatalytic character is lost at lower
nitrite:oxyHb ratios and as the oxysaturation of hemoglobin decreases (Grubina et al., 2007; Keszler et al., 2008).
Keszler et al. argued that in vivo the nitrite oxyHb reaction
will never become autocatalytic due to low nitrite:oxyHb
ratios and the presences of antioxidants such as catalase
and ascorbate (Keszler et al., 2008).
The reaction between nitrite and deoxyHb, given
in equation 1, was first studied by Brooks in 1937 and
extended by Doyle in 1981 (Brooks, 1937; Doyle et al., 1981).
The reaction leads to the formation of metHb and NO.
NO2− + HbFe2+ + H+ → HbFe 3+ + NO + OH− (1)
The reaction rate of nitrite with deoxyHb is dependent on
the conformation state of Hb. Therefore, under partial oxygenation or in the presence of metHb or HbNO the reaction rate increases (Huang et al., 2005a,b). NO produced
through the reduction of nitrite by deoxyHb rapidly reacts
with any unreacted deoxyHb. Therefore, the reaction of
nitrite with deoxyHb lead to a 1:1 production of metHb and
HbNO (Brooks, 1937; Huang et al., 2005b).
The reaction between deoxyHb/nitrite and oxyHb/
nitrite proceed in parallel with similar maximum reaction
rates at 50% saturation (Grubina et al., 2007). The reaction
of nitrite with deoxyHb provides a mechanism for production of NO. Data supports the formation and escape of NO
from the deoxyRBC. The Gladwin group has shown that
NO can be detected by chemiluminescence after reacting
Hb and nitrite (Huang et al., 2005b). Crawford et al. measured NO by chemiluminescence in the head space of deoxyRBCs reacted with nitrite (Crawford et al., 2006). Other
groups have also observed NO detected by chemiluminescence after reacting NO with RBCs (Ghosh et al., 2013;
Liu et al., 2015). Crawford et al. also measured stimulation of NO dependent processes such as cyclic guanosine
monophosphate production, inhibition of mitochondrial
respiration, and vasodilation which were sensitive to NO
scavenger C-PTIO (Crawford et al., 2006). Additionally,
work by Wajih et al. showed diminished platelet activation in the presence of nitrite and deoxygenated RBCs that
was inhibited by NO scavenger C-PTIO (Wajih et al., 2016).
However, when one considers the end product of the
nitrite deoxyHb reaction, NO, and its rapid interaction
with deoxyHb, or oxyHb which are abundant in the RBC,
the question of how NO escapes the RBC arises. Compartmentalization of NO or reaction intermediates could
reduce scavenging as well as the production of an alternative reactive nitrogen species. A metabolon has been

suggested where compartmentalization at the RBC membrane serves to concentrate NO in the membrane itself
(Gladwin et al., 2004).

N2O3
One possible reactive nitrogen signaling species that
may escape the RBC is N2O3. N2O3 does not react with the
ferrous heme and is freely diffusible. Basu and colleagues
detected the intermediate metHb-nitrite during the reaction of nitrite with deoxyHb and proposed that this
intermediate may react rapidly with NO to form N2O3, a
nitrosylating species (Basu et al., 2007; Roche et al., 2013).
One caveat of this reaction is that metHb-nitrite must outcompete any surrounding Hb for NO, therefore, compartmentalization of this reaction may be necessary for it to
play a physiological role. Friedman and coworkers have
suggested that a N2O3 bound Hb species forms during the
reaction of metHb and nitrite. They detected the formation
of an intermediate capable of S-nitrosation and GSNO formation under multiple conditions when metHb, NO, and
nitrite were mixed (Roche et al., 2013). Also, the addition
of reducing agent L-cysteine to metHb and nitrite reduced
a small population of metHb to deoxyHb. This deoxyHb
was then able to react with nitrite to form NO thus enabling the formation of the intermediate species (Roche
et al., 2015). However, studies have provided experimental or theoretical arguments against N2O3 formation (Tu
et al., 2008; Koppenol, 2012). On the other hand, if N2O3
does form it could potentially diffuse out of the RBC and
then form NO and NO2˙.

S-nitrosothiols
Another pool of NO derivatives that may escape or transport NO signaling within the RBC are S-nitrosothiols.
S-nitrosothiols react slowly with heme proteins (Spencer
et al., 2000), therefore, once an S-nitrosothiol is formed
the signal could be passed from S-nitrosothiol to S-nitrosothiol without reacting with deoxyHb.
One example of S-nitrosation (also referred to as
S-nitrosylation emphasizing its role in signaling) is the formation of SNO-Hb. Stamler et al. demonstrated the ability
of SNO-Hb to relax vessels through the hypoxic release of
NO activity from the β-93 cysteine of Hb (Stamler et al.,
1997; McMahon et al., 2002) and hypothesized the mechanism for this release was a decreased stability of SNO-Hb
in the deoxygenated T-state compared to the oxygenated
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R-state. In vitro research by Doctor and co-workers supported this theory by demonstrating SNO-Hb content
is coupled to Hb oxygen saturation (Doctor et al., 2005)
and Diesen et al. used blood vessel assays to show that
decreased RBC SNO-Hb content abolished vessel relaxation by hypoxic RBCs (Diesen et al., 2008). However, there
are many questions surrounding the SNO-Hb mechanism
of hypoxic vasodilation and its physiological relevance.
For more information on the hypoxic release of NO from
SNO-Hb we refer you to reviews by Allen et al. and Singel
et al. (Singel and Stamler, 2005; Allen and Piantadosi,
2006), but also suggest contrary literature (Gladwin et al.,
2002, 2003; Xu et al., 2003; Huang et al., 2006).
The above work does not consider the role of nitrite in
hypoxic vasodilation and raises the question of how SNO-Hb
is formed. In circulation SNO-Hb must be replenished following release in order for it to play a continuous role in
hypoxic vasodilation. Experiments into the formation of
SNO-Hb have ruled out the transfer of NO from HbNO to the
β-93 cysteine (Xu et al., 2003; Huang et al., 2006). Nagababu
et al. and Angelo et al. suggest a semi-stable metHb-NO
intermediate may form during nitrite reduction by deoxyHb
and would be capable of SNO-Hb formation, thereby linking
S-nitrosothiol formation with hypoxia and nitrite (Angelo
et al., 2006; Nagababu et al., 2006). But, Basu et al. were
unable to detect a stable metHb-NO intermediate and demonstrated metHb-nitrite is a major intermediate during
nitrite reduction by deoxyHb (Basu et al., 2007).
Additionally, a study by Isbell et al. in mice with a β-93
substitution of alanine for cysteine indicate SNO-Hb is not
essential for nitrite associated vasodilation (Isbell et al.,
2007). These findings provide strong evidence that militates against the role SNO-Hb in nitrite mediated hypoxic
vasodilation. However, a role for S-nitrosothiols is not ruled
out. Possible S-nitrosothiol mechanisms are nitrosation of
glutathione directly by metHb-NO, expected as a transient
intermediate in the reduction of nitrite by deoxyHb, or the
formation of SNO via N2O3. The formation of S-nitrosothiols that utilizes nitrite, provides a mechanism for hypoxic
nitrite reduction that produces NO bio-activity that avoids
scavenging by oxyHb o deoxyHb. However, the mechanism
of S-nitrosothiol formation requires further research and
reproducible detection of GSNO or other S-nitrosothiols
exported from the RBC have not been reported.

Role of the RBC membrane
Band 3, also known as AE1, is an abundant ion transporter in the RBC membrane and has also been proposed
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as a mechanism for SNO transport. Pawloski et al. proposed that SNO-Hb formed in the RBC would S-nitrosate
a cysteine on the cytosolic domain of Band 3 forming
SNO-AE1 (Pawloski et al., 2001). However, the subsequent export of NO bio-activity is still unclear but could
involve low molecular weight thiols. In the nitrite mediated vasodilation work of Isbell et al., using mice with β-93
cysteine substituted with alanine, argued against SNO-Hb
playing an important role in nitrite related vasodilation,
however, they did not rule out the role of S-nitrosothiol
formation all together (Isbell et al., 2007). Therefore,
low molecular weight SNO formed via nitrite reduction
could transnitrosylate AE1 and eventually escape the RBC
through and AE1 mechanism as proposed by Pawloski and
coworkers (Pawloski et al., 2001), although lack of S-nitrosothiol detection outside of the RBCs argues against this
hypothesis.
Kallakunta et al. investigated a role for protein
disulfide isomerase (PDI) in nitrite derived S-nitrosothiol
export from the RBC (Kallakunta et al., 2013). Their work
supports a process where under oxygenated conditions
in the presence of nitrite, PDI forms a complex with Hb,
is S-nitrosylated and then attaches to the surface of the
RBC. Upon deoxygenation SNO-PDI is released from the
membrane (Sliskovic et al., 2005). Past research has
shown a role for PDI in the import of NO derivatives into
various cell types (Zai et al., 1998; Ramachandran et al.,
2001; Bell et al., 2006). This new proposal puts forward
its importance as an exporter of vasodilatory activity. One
challenge to this hypothesis is that RBCs are not likely
to contain much PDI, so that only a small fraction of Hb
would be associated with PDI and nitrite-mediated PDI
S-nitrosylation would be inefficient.
In addition to its role in SNO export, the RBC membrane, specifically AE1, plays a role in nitrite transport.
For nitrite to react with hemoglobin and lead to NO bioactivation it must first enter the RBC. The transport of
nitrite across the RBC membrane is affected by the oxygen
saturation of hemoglobin (Vitturi et al., 2009). Early
studies showed that hemoglobin binds to the RBC membrane through an interaction with AE1 (Shaklai et al.,
1997; Galtieri et al., 2002; Chu et al., 2008). The binding of
hemoglobin to AE1controls its transport activity (Galtieri
et al., 2002; Drew et al., 2004). In the case of nitrite transport, oxygen saturation has no effect on the import of
nitrite by AE1 however, deoxygenation of the RBC reduces
nitrite export by AE-1 (Vitturi et al., 2009). This change in
nitrite export leads to a steady state level of nitrite in the
RBC. This steady state is maintained through the combination of faster scavenging of nitrite by deoxyHb balanced
with the decreased export of nitrite by deoxyHb bound
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AE1 (Vitturi et al., 2009). It should be noted however, that
substantial nitrite traverses the membrane directly as
nitrous acid.
The affinity of hemoglobin for the RBC membrane
is dependent upon its adduct. It has been suggested
that nitrite reacted Hb, which may lead to metHb-NO or
Hb-NO+, has a greater affinity for the RBC membrane than
deoxyHb and deoxyHb has a greater affinity for the RBC
membrane than oxyHb (Salgado et al., 2015). Salgado
argues that this greater affinity allows the lower concentrations of nitrite reacted Hb to compete with deoxyHb
and oxyHb for the AE1 binding sites. Additionally, the
binding of the nitrite reacted Hb to AE1 when nitrite is in
its reduced form [Hb(II)NO+ or Hb(III)NO] facilitates the
release of NO (Salgado et al., 2015); however, the lifetime
of this intermediate is debated (Nagababu et al., 2003;
Angelo et al., 2006; Basu et al., 2007). When nitrite reacted
Hb is bound to AE1, NO release occurs near the RBC membrane decreasing the distance NO would need to diffuse
to escape scavenging by Hb in the RBC, but escape is still
a great challenge. Therefore, Hb binding to the RBC membrane leads to yet another potential mechanism through
which the RBC membrane may facilitate NO bio-activity
from hypoxic nitrite reduction.
Protein AE1 was also suggested to be part of a metabolon involved in NO export from the RBC (Gladwin et al.,
2004). In this hypothesis, the metabolon (possibly on
a RBC lipid raft) includes carbonic anhydrase which

provides protons for the nitrite reaction (see equation 1)
and AE1 which binds to Hb that reduces nitrite to NO. NO
itself is them exported (Gladwin et al., 2004).
Lastly, recent work by our lab has shown a potential role for RBC membrane S-nitrosylation in nitrite
bioactivation (Wajih et al., 2016). We showed nitrite
inhibits platelet activation when in the presence of
deoxyRBCs. The addition of SNAP, a membrane impermeable nitrosating agent, to RBCs had a similar effect on
platelet activation, suggesting a role for RBC membrane
S-nitrosylation. The addition of N-ethylmaleimide and
5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), thiol blocking agents, eliminated the abrogation of platelet activation by nitrite and deoxyRBCs (Wajih et al., 2016). These
data suggest a role for S-nitrosylation of the external
RBC membrane in the pathway of nitrite bioactivation.
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Figure 2: Nitrite consumption by RBCs treated or not treated with
DTNB.
For RBC treated with DTNB, we incubated RBCs at 50% Hct with 2.5
mm DTNB in the dark for 1 h at room temperature. Next, we washed
the RBCs three times by centrifugation to remove extra DTNB and
deoxygenated them with nitrogen. Nitrite (0.1 mm) was added to
deoxyRBCs at 15% Hct and nitrite remaining in the solution was
determined at 15 and 30 min intervals by ozone chemiluminescence.
There was no difference in the consumption of nitrite by RBCs
exposed or not exposed to DTNB.

Figure 3: Physiological application of nitrite reduction by the RBC.
Nitrite and the deoxygenated RBC produce NO and other reactive
nitrogen signaling species in deoxygenated conditions as shown
through vessel assays and platelet activation studies, tending to
increase blood flow into areas of low oxygen. Recent data using
platelet activation to measure NO bioavailability show that NO bioavailability is greatest when nutrients such as leucine and glucose
are low, suggesting that blood flow may also be directed to areas of
low nutrients.
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NO. However, in the RBC NO would be quickly scavenged
by the surrounding Hb. Therefore, researchers have proposed and tested many hypotheses involving NO or related
reactive nitrogen signaling species that avoid scavenging
(Figure 4). A dominant element in many hypotheses is the
formation of S-nitrosothiols however, the mechanism for
their formation and transport remains elusive.
Currently, research has suggested (1) the infusion of
nitrite and deoxyRBCs produces vasodilation, (2) there is
an arterial to venous nitrite gradient, (3) nitrite transport
through the RBC membrane is partially controlled by AE-1,
(4) Hb interacts preferentially with AE1 on the RBC membrane according to its adduct, (5) PDI, nitrite and hemoglobin lead to PDI-S-nitrosylation, (6) leucine and glucose
diminish the production of a species that abrogates
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As stated above, a new paradigm has been proposed
whereby RBCs, upon sensing hypoxia and acidosis, reduce
nitrite to NO thereby increasing blood flow to where it is
needed.
Recent research by our lab found that physiological
levels of leucine and glucose inhibit nitrite bioactivation
by RBCs through a mechanism that is not related to SNO
export by L-type amino acid transporter 1 (Wajih et al.,
2016). This adds further complexity to the mechanism
of nitrite bioactivation. Although this novel work needs
further exploration, it suggests that nitrite bioactivation
by RBCs not only increases blood flow to areas of low
oxygen, but also to areas of low nutrients (Figure 3).
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To further support this hypothesis and exclude an effect
of DTNB on nitrite uptake we measured nitrite uptake by
the RBC in the presence of DTNB. Nitrite uptake by RBCs
was not altered by the addition of DTNB (Figure 2). Thus,
RBC surface nitrosation appears to play a part in nitrite
bioactivation by the RBC as measured by inhibition of
platelet activation.

Figure 4: Potential players in the escape of NO and other reactive
nitrogen signaling species from the RBC.
In the center of the RBC is the reaction between nitrite and deoxyHb
which leads to NO production. However, NO produced inside the
RBC is quickly scavenged by Hb leading to the question of how NO
escapes the RBC. Starting at the top and moving clockwise: We
showed S-nitrosylation of the RBC membrane is necessary for platelet inhibition. Salgado et al. showed preferential binding of nitrite
reacted Hb to AE1 and suggested this binding would place NO production at the membrane making it more likely to escape scavenging. Stamler et al. suggested AE1 may become S-nitrosylated through
transnitrosation reactions and facilitate transport of S-nitrosothiols.
Gladwin et al. hypothesized a membrane metabolon consisting of
AE1, carbonic anhydrase, deoxyHb and nitrite that would compartmentalize NO production by the metabolon to the membrane thereby
facilitating NO escape. Kallakunta et al. showed a reaction between
oxyHb, nitrite and PDI leading to PDI S-nitrosylation and argued in
vivo SNO-PDI may embed in the membrane and be release during
deoxygenation of the RBC. Lastly, we showed the reaction between
metHb, nitrite and NO can produce N2O3 which could escape through
the RBC membrane or form S-nitrosothiols which could escape
through transnitrosylation, as previously proposed.

platelet activation and (6) S-nitrosylation of the RBC membrane produces a species capable of decreasing platelet
activation.
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